An early feasibility study to evaluate the safety and efficacy of Delphi Revascularization device for clot retrieval. This is for hospital patients with Anterior circulation ischemic stroke. Up to 8hrs of symptom onset or last known well time. Read More
At least 18 years of age at time of consent;
The patient or patient’s LAR has signed and dated an ICD using the Institutional Review Board (IRB) and Medtronic Approved ICD and agrees to comply with protocol requirements. Health Insurance Portability and Accountability Act of 1996 (HIPAA) authorization has been provided and signed by the patient or patient’s LAR
Has baseline N...
Participants will be asked questions about a new cognitive processing test (how fast they can think). This study involves a single visit which takes about 20-minutes at the Conventus Medical Center in Buffalo. 50 multiple sclerosis patients and 50 healthy people will be enrolled. Read More
Physician established diagnosis of multiple sclerosis
18 years of age or older
Able to read and speak English
This sub-study is for Parkinson Disease (PD) patients enrolled in a previous lithium trial with Dr. Guttuso. The additional data from this sub-study may help bolster the current evidence that lithium positively affects blood biomarkers and support further research on lithium’s potential to slow PD progression. Read More
1. Diagnosed with PD according to the UK Brain Bank Criteria.23
2. 45-80 years of age.
3. Enrolled in the previous lithium trial.
4. No history of cardiac arrhythmias besides atrial fibrillation that is rate controlled.
5. No unstable cardiac, medical or psychiatric condition in the opinion of the PI.
6. No current use of illicit drugs or current alcohol abuse in the o...
This study enrolls adults who have had a brain hemorrhage within the last 7 days. The purpose of the study is to learn whether it is better to keep taking or stop taking the medication statin after having a brain bleed. Read More
Adults ages 50+.
Have had bleeding in the brain (brain hemorrhage) within the last 7 days.
Were taking a statin drug.
People who may be eligible for this study will be contacted by study staff directly. Eligible participants will be inpatients of Buffalo General/Gates Vascular Institute.
This study enrolls people who have been diagnosed with a blood clot blocking an artery in their brain (stroke). The blocked artery is opened by removing the blood clot using a small catheter (thin tube) device that is inserted into an artery through your arm or leg that leads to your brain. The purpose of this study is to find out if this specific new investigational catheter (ZOOM) leads to improved outcomes at 90 days. Read More
Adults ages 18+
Diagnosed with a stroke
This study enrolls people who have had a brain aneurysm who will be treated with endovascular coil embolization. This procedure blocks blood flow to the bulging blood vessel in the brain. The purpose of this study is to learn how well SMART COIL System works for this type of procedure in everyday practice. The system is cleared by the FDA. Read More
Adults ages 18+.
Will be having embolization of intracranial aneurysms procedure.
This study enrolls people with Multiple Sclerosis who have already enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC). The purpose of this study is to learn more about the experiences of people with MS who are having a natalizumab infusion. Read More
Adults ages 18+.
Have multiple sclerosis.
Are enrolled in the New York State Multiple Sclerosis Consortium (NYSMSC),
Have taken natalizumab for the treatment of MS for at least six months.
This study enrolls current patients who have MS. The purpose of this study is to gain a better understanding of Severely Affected Patients with MS to lead to better early identification, treatment and care. Read More
Adults ages 30-75.
Must have been invited to participate by a provider.